GW
Gena Wang Barclays Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $78 |
27%
upside
| Overweight | 2 days ago |
|
2
Cytokinetics
CYTK
$6.35B
| $53.04 | $71 |
34%
upside
| Overweight | 2 days ago |
|
3
Kodiak Sciences
KOD
$557M
| $10.54 | $7 |
34%
downside
| Underweight | 22 days ago |
|
4
Regenxbio
RGNX
$490M
| $9.71 | $37 |
281%
upside
| Overweight | 28 days ago |
|
5
Avidity Biosciences
RNA
$6.48B
| $50.37 | $62 |
23%
upside
| Overweight | 28 days ago |
|
6
CRISPR Therapeutics
CRSP
$4.99B
| $54.88 | $56 |
2%
upside
| Equal-Weight | 1 month ago |
|
7
Beam Therapeutics
BEAM
$2.11B
| $20.89 | $21 |
1%
upside
| Equal-Weight | 1 month ago |
|
8
Moderna
MRNA
$9.78B
| $25.13 | $31 |
23%
upside
| Equal-Weight | 1 month ago |
|
9
Alnylam Pharmaceuticals
ALNY
$59.2B
| $451.99 | $460 |
2%
upside
| Overweight | 1 month ago |
|
10
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $22 |
18%
upside
| Equal-Weight | 1 month ago |
|
11
PTC Therapeutics
PTCT
$4.55B
| $57.24 | $46 |
20%
downside
| Equal-Weight | 1 month ago |
|
12
Solid Biosciences
SLDB
$428M
| $5.50 | $10 |
82%
upside
| Overweight | 3 months ago |
|
|
CLLS
13
Cellectis
CLLS
$267M
| $2.66 | $4 |
50%
upside
| Overweight | 3 months ago |
|
14
4D Molecular Therapeutics
FDMT
$339M
| $7.26 | $38 |
423%
upside
| Overweight | 3 months ago |
|
15
BioCryst Pharmaceuticals
BCRX
$1.73B
| $8.26 | $11 |
33%
upside
| Equal-Weight | 4 months ago |
|
16
Vir Biotechnology
VIR
$733M
| $5.28 | $31 |
487%
upside
| Overweight | 6 months ago |
|
17
Intellia Therapeutics
NTLA
$1.29B
| $12.06 | $26 |
116%
upside
| Overweight | 6 months ago |
|
18
Vertex Pharmaceuticals
VRTX
$102B
| $396.16 | $467 |
18%
upside
| Equal-Weight | 6 months ago |
|
19
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $86 |
49%
upside
| Overweight | 11 months ago |
|
20
Ultragenyx Pharmaceutical
RARE
$3.06B
| $31.79 | $81 |
155%
upside
| Overweight | 1 year ago |
|
21
Legend Biotech
LEGN
$6.66B
| $36.08 | $94 |
161%
upside
| Overweight | 1 year ago |
|
22
Zymeworks
ZYME
$1.14B
| $15.03 | $9 |
40%
downside
| Equal-Weight | 2 years ago |
|
23
Arcturus Therapeutics
ARCT
$485M
| $17.87 | $25 |
40%
upside
| Equal-Weight | 2 years ago |
|
24
MeiraGTx Holdings
MGTX
$619M
| $7.69 | $18 |
134%
upside
| Overweight | 3 years ago |
|